BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 34834316)

  • 1. miRNA Delivery by Nanosystems: State of the Art and Perspectives.
    Moraes FC; Pichon C; Letourneur D; Chaubet F
    Pharmaceutics; 2021 Nov; 13(11):. PubMed ID: 34834316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progress in microRNA delivery.
    Zhang Y; Wang Z; Gemeinhart RA
    J Control Release; 2013 Dec; 172(3):962-74. PubMed ID: 24075926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent Advances in miRNA Delivery Systems.
    Dasgupta I; Chatterjee A
    Methods Protoc; 2021 Jan; 4(1):. PubMed ID: 33498244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delivery of therapeutic miRNA using polymer-based formulation.
    Ban E; Kwon TH; Kim A
    Drug Deliv Transl Res; 2019 Dec; 9(6):1043-1056. PubMed ID: 31049843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving miRNA Delivery by Optimizing miRNA Expression Cassettes in Diverse Virus Vectors.
    Herrera-Carrillo E; Liu YP; Berkhout B
    Hum Gene Ther Methods; 2017 Aug; 28(4):177-190. PubMed ID: 28712309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Applications of nanotechnologies for miRNA-based cancer therapeutics: current advances and future perspectives.
    Bravo-Vázquez LA; Méndez-García A; Rodríguez AL; Sahare P; Pathak S; Banerjee A; Duttaroy AK; Paul S
    Front Bioeng Biotechnol; 2023; 11():1208547. PubMed ID: 37576994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-targeted therapeutics for lung cancer treatment.
    Xue J; Yang J; Luo M; Cho WC; Liu X
    Expert Opin Drug Discov; 2017 Feb; 12(2):141-157. PubMed ID: 27866431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNAi-based therapeutics and tumor targeted delivery in cancer.
    Kara G; Calin GA; Ozpolat B
    Adv Drug Deliv Rev; 2022 Mar; 182():114113. PubMed ID: 35063535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-based therapeutics in cardiovascular disease: screening and delivery to the target.
    Mellis D; Caporali A
    Biochem Soc Trans; 2018 Feb; 46(1):11-21. PubMed ID: 29196609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-viral based miR delivery and recent developments.
    Labatut AE; Mattheolabakis G
    Eur J Pharm Biopharm; 2018 Jul; 128():82-90. PubMed ID: 29679644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. microRNAs in Cardiovascular Disease: Small Molecules but Big Roles.
    Yan B; Wang H; Tan Y; Fu W
    Curr Top Med Chem; 2019; 19(21):1918-1947. PubMed ID: 31393249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delivery of MicroRNAs by Chitosan Nanoparticles to Functionally Alter Macrophage Cholesterol Efflux in Vitro and in Vivo.
    Nguyen MA; Wyatt H; Susser L; Geoffrion M; Rasheed A; Duchez AC; Cottee ML; Afolayan E; Farah E; Kahiel Z; Côté M; Gadde S; Rayner KJ
    ACS Nano; 2019 Jun; 13(6):6491-6505. PubMed ID: 31125197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent progress in microRNA delivery for cancer therapy by non-viral synthetic vectors.
    Wang H; Jiang Y; Peng H; Chen Y; Zhu P; Huang Y
    Adv Drug Deliv Rev; 2015 Jan; 81():142-60. PubMed ID: 25450259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid Nanoparticles to Deliver miRNA in Cancer.
    Campani V; De Rosa G; Misso G; Zarone MR; Grimaldi A
    Curr Pharm Biotechnol; 2016; 17(8):741-9. PubMed ID: 27215371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Host miRNA and immune cell interactions: relevance in nano-therapeutics for human health.
    Sharma Y; Saini AK; Kashyap S; Chandan G; Kaur N; Gupta VK; Thakur VK; Saini V; Saini RV
    Immunol Res; 2022 Feb; 70(1):1-18. PubMed ID: 34716546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miRacle of microRNA-Driven Cancer Nanotherapeutics.
    Kara G; Arun B; Calin GA; Ozpolat B
    Cancers (Basel); 2022 Aug; 14(15):. PubMed ID: 35954481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA Targeting to Modulate Tumor Microenvironment.
    Kuninty PR; Schnittert J; Storm G; Prakash J
    Front Oncol; 2016; 6():3. PubMed ID: 26835418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanostructured lipid carriers for MicroRNA delivery in tumor gene therapy.
    Wang H; Liu S; Jia L; Chu F; Zhou Y; He Z; Guo M; Chen C; Xu L
    Cancer Cell Int; 2018; 18():101. PubMed ID: 30008618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA therapeutics: the emerging anticancer strategies.
    Jain CK; Gupta A; Dogra N; Kumar VS; Wadhwa G; Sharma SK
    Recent Pat Anticancer Drug Discov; 2014; 9(3):286-96. PubMed ID: 24605908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategies to deliver microRNAs as potential therapeutics in the treatment of cardiovascular pathology.
    Chistiakov DA; Sobenin IA; Orekhov AN
    Drug Deliv; 2012 Nov; 19(8):392-405. PubMed ID: 23173580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.